Acadian Asset Management’s Pulmonx LUNG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$287K Buy
223,141
+56,800
+34% +$78.2K ﹤0.01% 1573
2026
Q1
$212K Sell
166,341
-11,692
-7% -$19.3K ﹤0.01% 1565
2025
Q4
$391K Sell
178,033
-33,227
-16% -$62.5K ﹤0.01% 1379
2025
Q3
$341K Buy
211,260
+185,744
+728% +$389K ﹤0.01% 1300
2025
Q2
$65K Buy
+25,516
New +$101K ﹤0.01% 1454
2023
Q3
Sell
-26,293
Closed -$343K 1765
2023
Q2
$343K Buy
+26,293
New +$322K ﹤0.01% 1150

Other funds holding LUNG

Acadian Asset Management's LUNG Position: Q2 2026 in Review

Acadian Asset Management increased its Pulmonx (LUNG) stake by 34% in Q2 2026, buying an estimated $78.2K and bringing the position to 223,141 shares worth $287K. The position accounts for ﹤0.01% of the portfolio, ranked #1573.

Acadian Asset Management first reported a position in LUNG in Q2 2023 and has held it in 6 quarters since. The position peaked at $391K in Q4 2025. 108 funds tracked by Wall St. Rank hold LUNG as of Q2 2026.

  • Acadian Asset Management held 223,141 shares of Pulmonx worth $287K as of Q2 2026.
  • Acadian Asset Management bought 56,800 Pulmonx shares in Q2 2026, an estimated $78.2K.
  • Pulmonx made up ﹤0.01% of Acadian Asset Management's portfolio in Q2 2026, its #1573 holding.
  • Acadian Asset Management first reported a position in Pulmonx in Q2 2023 and has held it in 6 quarters since.
  • Acadian Asset Management's Pulmonx position peaked at $391K in Q4 2025.
  • 108 funds tracked by Wall St. Rank held Pulmonx as of Q2 2026.

Based on Acadian Asset Management's 13F filing for Q2 2026, filed 13 Aug 2026.